← FDA Drug Approvals (Drugs@FDA)
METHYLPHENIDATE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2023-02-07
Drug application
- FDA Application #
ANDA214202- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METHYLPHENIDATE HYDROCHLORIDE
- Generic name
- Methylphenidate Hydrochloride
- Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE, CHEWABLE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA
- First approval
- 2023-02-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown